Lyle Ostrow, M.D., Ph.D. is a Neurologist, and ALS Researcher at the Lewis Katz School of Medicine at Temple University. He is a member of the Scientific Advisory Board for Everything ALS and the Board of Directors of the ALS Hope Foundation. He is Director of the Temple University ALS Postmortem Core, which is funded by a collaboration with the CDC National ALS Registry.  He is also Director of the Temple Nerve and Muscle Biopsy Service and Neuromuscular Pathology Lab.

​

Dr. Ostrow is Chair of the Programmatic Panel for the Department of Defense ALS Research Program, presently the largest dedicated annual funder of ALS therapeutic discovery and validation. He helped lead ALSRP efforts to develop and refine funding mechanisms to help novel treatments advance from the lab to clinical trials, emphasize biomarker and clinical outcome development, and encourage open data and resource sharing. He serves on several ALS steering committees, advisory boards, and review panels, and has given 40+ invited talks, grand rounds, and keynote lectures on ALS research, biomarkers, postmortem tissue banking, and harmonizing multicenter research efforts and core resources.